GC Therapeutics
Cory Smith is an experienced individual who has worked in various prestigious institutions such as GC Therapeutics, Harvard Medical School, and Johns Hopkins School of Medicine. With a background in Microbiology and Cell Science, Cory's research has focused on using genome editing technologies to study genetic variants in human iPSCs for functional interrogation of genetic diseases. Additionally, Cory has experience in microbial and environmental genomics, conducting sequencing and analysis projects related to fish pathogens. Graduating with a Ph.D. in Human Genetics, Cory has a strong academic background in the field.
GC Therapeutics
1 followers
GC Therapeutics Inc. (GCTx) uses synthetic biology to program patient-derived stem cells into any cell type with best-in-class efficiency (up to 10X), speed (up to 100X) and scalability. We dictate cells fates in a single step and have validated cells for many applications. We have also developed SuperCells™ by tailoring cells for specific diseases. The core technology of GCTx was conceived, invented and perfected in Professor George Church’s lab at Harvard Medical School. We are a group of passionate biologists and tissue engineers whose goal is to bring this breakthrough approach to patients.